Medpace Holdings Inc
MEDPHealthcare·Diagnostics & Research·USA·Large·NASD·Nov 11 • 3:59 PM ET
Price
MEDP against its 20, 50 and 200-day averages4.2% under the 52-week high of 693.97 on 28 Oct 2026. 52-week low 373.00 on 23 Apr 2026. Last 15 sessions, 9.8% high to low
Volume 0.52× normal · the line is the 50-bar volume average
Profile
MEDPMedpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. It operates through the following geographical segments: North America, Europe, Asia, South America, Africa and Australia. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH.
| Index | RUI |
|---|---|
| Employees | 6200 |
| IPO | Aug 11, 2016 |
| Beta | 1.11 |
| ATR, 14d | 21.11 |
| Rel volume | 0.52 |
| Short float | 6.09% |
| Insider own | 18.79% |
| Inst own | 88.87% |
Snapshot
6 groupsValuation
| Index | RUI |
|---|---|
| Market Cap | 18.59B |
| Enterprise Value | 18.06B |
| Income | 517.83M |
| Sales | 2.84B |
| Book/sh | 20.97 |
| Cash/sh | 25.22 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Dividend Gr. 3/5Y | - - |
| Payout | 0.00% |
| Employees | 6200 |
| IPO | Aug 11, 2016 |
Ratios
| P/E | 36.85 |
|---|---|
| Forward P/E | 33.75 |
| PEG | 2.60 |
| P/S | 6.55 |
| P/B | 31.70 |
| P/C | 26.36 |
| P/FCF | 27.85 |
| EV/EBITDA | 28.47 |
| EV/Sales | 6.36 |
| Quick Ratio | 0.83 |
| Current Ratio | 0.83 |
| Debt/Eq | 0.29 |
| LT Debt/Eq | 0.25 |
| Option/Short | Yes / Yes |
Earnings
| EPS (ttm) | 18.04 |
|---|---|
| EPS next Y | 19.70 |
| EPS next Q | 4.83 |
| EPS this Y | 19.38% |
| EPS next Y | 7.98% |
| EPS next 5Y | 12.99% |
| EPS past 3/5Y | 28.02% 31.79% |
| Sales past 3/5Y | 20.12% 22.27% |
| EPS Y/Y TTM | 25.24% |
| Sales Y/Y TTM | 20.35% |
| EPS Q/Q | 25.63% |
| Sales Q/Q | 8.50% |
| Earnings | Oct 21 AMC |
| EPS/Sales Surpr. | 9.11% 0.21% |
Ownership
| Insider Own | 18.79% |
|---|---|
| Insider Trans | -6.65% |
| Inst Own | 88.87% |
| Inst Trans | 2.00% |
| ROA | 25.54% |
| ROE | 117.88% |
| ROIC | 70.84% |
| Gross Margin | 28.18% |
| Oper. Margin | 21.39% |
| Profit Margin | 18.24% |
| SMA20 | 1.44% |
| SMA50 | 6.02% |
| SMA200 | 25.09% |
| Trades | - |
Technical
| Shs Outstand | 27.90M |
|---|---|
| Shs Float | 22.72M |
| Short Float | 6.09% |
| Short Ratio | 5.33 |
| Short Interest | 1.38M |
| 52W High | 693.97 -4.21% |
| 52W Low | 373.00 78.22% |
| Volatility | 3.68% 3.54% |
| ATR (14) | 21.11 |
| RSI (14) | 55.86 |
| Beta | 1.11 |
| Rel Volume | 0.52 |
| Avg Volume | 259.73K |
| Volume | 134,609 |
Performance
| Perf Week | 1.22% |
|---|---|
| Perf Month | 9.00% |
| Perf Quarter | 14.23% |
| Perf Half Y | 56.87% |
| Perf YTD | 18.36% |
| Perf Year | 10.29% |
| Perf 3Y | 141.42% |
| Perf 5Y | 200.84% |
| Perf 10Y | 1835.28% |
| Recom | 2.86 |
| Target Price | 674.75 |
| Prev Close | 664.54 |
| Price | 664.77 |
| Change % | 0.03% |
Analyst ratings
latest 10 of 20| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| Sep 30, 2026 | Resumed | UUBS | Neutral | $673 | +1.2% |
| Jul 08, 2026 | Downgrade | RRobert W. Baird | Outperform → Neutral | $547 | -17.7% |
| Jul 07, 2026 | Downgrade | JJefferies | Buy → Hold | $515 | -22.5% |
| Mar 06, 2026 | Upgrade | BBarclays | Underweight → Equal Weight | $500 | -24.8% |
| Mar 03, 2026 | Initiated | RRBC Capital Mkts | Outperform | $522 | -21.5% |
| Feb 18, 2026 | Upgrade | TTD Cowen | Sell → Hold | $419 | -37.0% |
| Feb 13, 2026 | Upgrade | JJefferies | Hold → Buy | $560 | -15.8% |
| Feb 10, 2026 | Upgrade | RRobert W. Baird | Neutral → Outperform | $564 | -15.2% |
| Nov 13, 2025 | Initiated | BBMO Capital Markets | Market Perform | $600 | -9.7% |
| Oct 02, 2025 | Downgrade | BBarclays | Equal Weight → Underweight | $425 | -36.1% |
Peers
Mkt cap| Ticker | Company | Mkt cap |
|---|---|---|
| ICLR | Icon Plc | 14.96B |
| IQV | IQVIA Holdings Inc | 45.24B |
| FTRE | Fortrea Holdings Inc | 1.97B |
| LH | Labcorp Holdings Inc | 30.23B |
| CRL | Charles River Laboratories International Inc | 16.42B |
| TMO | Thermo Fisher Scientific Inc | 265.92B |
| VEEV | Veeva Systems Inc | 49.34B |
| TEM | Tempus AI Inc | 14.49B |
| CERT | Certara Inc | 1.79B |
| AZTA | Azenta Inc | 2.14B |
Insider trading
latest 14 of 95| Insider | Relationship | Date | Transaction | Cost | Shares | Value | Total held | Form |
|---|---|---|---|---|---|---|---|---|
| EWALD STEPHEN P | General Counsel & Corp. Secy. | Oct 29 '26 | Sale | 690.00 | 1,245 | 859,050 | 19,098 | Nov 02 06:24 PM |
| EWALD STEPHEN P | Officer | Oct 29 '26 | Proposed Sale | 690.00 | 1,245 | 859,050 | Oct 29 03:36 PM | |
| BURWIG SUSAN E | Exec. VP, Operations | Oct 26 '26 | Option Exercise | 166.73 | 328 | 54,687 | 57,952 | Oct 28 04:23 PM |
| BURWIG SUSAN E | Exec. VP, Operations | Oct 26 '26 | Sale | 677.00 | 16,060 | 10,872,620 | 57,624 | Oct 28 04:23 PM |
| BURWIG SUSAN E | Exec. VP, Operations | Oct 27 '26 | Sale | 677.00 | 3,940 | 2,667,380 | 54,012 | Oct 28 04:23 PM |
| BURWIG SUSAN E | Officer | Oct 27 '26 | Proposed Sale | 677.00 | 3,940 | 2,667,380 | Oct 27 10:23 AM | |
| BURWIG SUSAN E | Officer | Oct 26 '26 | Proposed Sale | 677.00 | 16,060 | 10,872,620 | Oct 26 04:24 PM | |
| BURWIG SUSAN E | Exec. VP, Operations | Oct 21 '26 | Option Exercise | 166.73 | 2,700 | 450,171 | 73,684 | Oct 23 04:11 PM |
| BURWIG SUSAN E | Exec. VP, Operations | Oct 12 '26 | Option Exercise | 166.73 | 3,000 | 500,190 | 70,984 | Oct 14 04:14 PM |
| BURWIG SUSAN E | Exec. VP, Operations | Oct 07 '26 | Option Exercise | 166.73 | 2,000 | 333,460 | 67,984 | Oct 09 04:14 PM |
| Troendle August J. | President & CEO | Sep 29 '26 | Sale | 621.02 | 26,701 | 16,581,855 | 360,191 | Oct 01 05:43 PM |
| Troendle August J. | President & CEO | Sep 30 '26 | Sale | 625.47 | 21,966 | 13,739,074 | 338,225 | Oct 01 05:43 PM |
| Troendle August J. | President & CEO | Sep 28 '26 | Sale | 620.07 | 2,410 | 1,494,369 | 386,892 | Sep 29 04:13 PM |
| Troendle August J. | President & CEO | Sep 25 '26 | Sale | 620.60 | 154 | 95,572 | 389,302 | Sep 29 04:13 PM |
Held by
AUM| Ticker | Company | AUM |
|---|---|---|
| IJH | iShares Core S&P Mid-Cap ETF | AUM: 124.48B |
| VTI | Vanguard Morningstar Total Stock Market ETF | AUM: 687.42B |
| VB | Vanguard Morningstar Small-Cap ETF | AUM: 79.59B |
| XMHQ | Invesco S&P MidCap Quality ETF | AUM: 5.81B |
| VBK | Vanguard Morningstar Small-Cap Growth ETF | AUM: 22.34B |
| VXF | Vanguard Extended Market Index ETF | AUM: 30.47B |
| IBB | iShares Biotechnology ETF | AUM: 11.36B |
| MDY | State Street SPDR S&P MIDCAP 400 ETF Trust | AUM: 26.22B |
| IJK | iShares S&P Mid-Cap 400 Growth ETF | AUM: 10.46B |
| IWP | iShares Russell Mid-Cap Growth ETF | AUM: 18.09B |
News
latest 14 of 196- Medpace Beats And Raises Profit Outlook As Record Bookings Offset A Sharp Revenue Slowdown (Earnings Whispers)
- Medpace beats Q3 estimates but guides below on revenue (Investing.com) +6.43%
- Medpace: Q3 Earnings Snapshot (Associated Press)
- Medpace Holdings, Inc. Reports Third Quarter 2026 Results (Business Wire)
- Medpace Holdings, Inc. to Report Third Quarter 2026 Financial Results on October 21, 2026 (Business Wire)
- This Healthcare Services Stock Has 37% Upside (Barrons.com)
- Medpace Holdings Inc (MEDP) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Record ... (GuruFocus.com) +14.71%
- Medpace: Q2 Earnings Snapshot (Associated Press)
- Medpace Holdings, Inc. Reports Second Quarter 2026 Results (Business Wire)
- Dollar Tree upgraded, PayPal initiated: Wall Street's top analyst calls (The Fly)
- SpaceX initiated, Cloudflare upgraded: Wall Street's top analyst calls (The Fly)
- Medpace Holdings, Inc. to Report Second Quarter 2026 Financial Results on July 22, 2026 (Business Wire)
- Medpace Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MEDP (PR Newswire)
- Medpace Holdings Inc (MEDP) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amid Rising ... (GuruFocus.com)
Quarterly earnings
actual against estimate| Period | Reported | EPS act | EPS est | EPS rep | Sales act | Sales est | Analysts |
|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-10-21 | 4.840 | 4.436 | 4.840 | 716 | 714.47 | 11 |
| 2026Q2 | 2026-07-22 | 4.250 | 3.978 | 4.250 | 707.33 | 689.51 | 10 |
| 2026Q1 | 2026-04-22 | 4.280 | 3.921 | 4.277 | 706.6 | 697.6 | 10 |
| 2025Q4 | 2026-02-09 | 4.670 | 4.185 | 4.666 | 708.45 | 689.31 | 10 |
| 2025Q3 | 2025-10-22 | 3.860 | 3.535 | 3.857 | 659.9 | 641 | 9 |
| 2025Q2 | 2025-07-21 | 3.100 | 2.983 | 3.097 | 603.31 | 538.77 | 9 |
| 2025Q1 | 2025-04-21 | 3.670 | 3.060 | 3.673 | 558.57 | 526.34 | 8 |
| 2024Q4 | 2025-02-10 | 3.670 | 2.939 | 3.671 | 536.6 | 534.77 | 7 |
| 2024Q3 | 2024-10-21 | 3.010 | 2.771 | 3.005 | 533.32 | 540.99 | 7 |
| 2024Q2 | 2024-07-22 | 2.750 | 2.539 | 2.754 | 528.1 | 528.4 | 7 |
| 2024Q1 | 2024-04-22 | 3.200 | 2.466 | 3.205 | 511.04 | 512.39 | 6 |
| 2023Q4 | 2024-02-12 | 2.460 | 2.221 | 2.459 | 498.4 | 498.72 | 5 |
| 2023Q3 | 2023-10-23 | 2.220 | 2.046 | 2.220 | 492.5 | 475.79 | 5 |
| 2023Q2 | 2023-07-24 | 1.930 | 1.914 | 1.933 | 460.87 | 433.75 | 5 |
| 2023Q1 | 2023-04-24 | 2.270 | 1.815 | 2.265 | 434.07 | 401.81 | 5 |
| 2022Q4 | 2023-02-13 | 2.120 | 1.786 | 2.117 | 394.1 | 386.01 | 5 |
Annual earnings
| Period | EPS act | EPS est | EPS rep | Sales act | Sales est |
|---|---|---|---|---|---|
| 2019FY | 3.020 | 2.919 | 2.666 | 860.97 | 851.66 |
| 2020FY | 3.840 | 3.743 | 3.843 | 925.93 | 912.22 |
| 2021FY | 4.810 | 4.780 | 4.812 | 1,142 | 1,143 |
| 2022FY | 7.280 | 6.969 | 7.283 | 1,460 | 1,452 |
| 2023FY | 8.880 | 8.642 | 8.876 | 1,886 | 1,886 |
| 2024FY | 12.630 | 11.936 | 12.630 | 2,109 | 2,106 |
| 2025FY | 15.280 | 14.805 | 15.280 | 2,530 | 2,511 |
| 2026FY | - | 18.241 | - | - | 2,850 |
| 2027FY | - | 19.696 | - | - | 3,017 |
| 2028FY | - | 22.041 | - | - | 3,278 |
| 2029FY | - | 24.457 | - | - | 3,497 |
| 2030FY | - | 27.323 | - | - | 3,914 |
Estimate revisions
last 14 periods| Period | Type | Date | Estimates | Up | Down | Mean | Low | High |
|---|---|---|---|---|---|---|---|---|
| 2026Q4 | S | 2026-10-23 | 11 | 2 | 3 | 718.4 | 710 | 725.04 |
| 2026Q4 | S | 2026-10-22 | 11 | 2 | 3 | 718.4 | 710 | 725.04 |
| 2026Q4 | S | 2026-10-21 | 11 | 0 | 0 | 720.89 | 708.45 | 738.04 |
| 2026Q4 | S | 2026-10-06 | 11 | 0 | 0 | 720.89 | 708.45 | 738.04 |
| 2026Q4 | S | 2026-10-05 | 11 | 10 | 0 | 720.89 | 708.45 | 738.04 |
| 2026Q4 | S | 2026-09-28 | 11 | 10 | 0 | 720.89 | 708.45 | 738.04 |
| 2026Q4 | S | 2026-09-16 | 10 | 10 | 0 | 720.42 | 708.45 | 737.83 |
| 2026Q4 | S | 2026-09-11 | 10 | 10 | 0 | 720.42 | 708.45 | 737.83 |
| 2026Q4 | S | 2026-07-24 | 10 | 10 | 0 | 720.42 | 708.45 | 737.83 |
| 2026Q4 | S | 2026-07-23 | 10 | 10 | 0 | 720.42 | 708.45 | 737.83 |
| 2026Q4 | S | 2026-07-22 | 10 | 0 | 0 | 694.39 | 674.09 | 709.7 |
| 2026Q4 | S | 2026-07-14 | 10 | 0 | 0 | 694.39 | 674.09 | 709.7 |
| 2026Q4 | S | 2026-07-07 | 10 | 0 | 0 | 694.7 | 674.09 | 709.7 |
| 2026Q4 | S | 2026-07-06 | 10 | 0 | 7 | 694.8 | 674.09 | 709.75 |
Estimate history
| EPS, annual | 0.98 | 1.975 | 2.666 | 3.843 | 4.812 | 7.283 | 8.876 | 12.63 | 15.278 | 18.0377 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
| EPS, quarterly | 3.005 | 3.671 | 3.673 | 3.097 | 3.857 | 4.666 | 4.277 | 4.25 | 4.845 | |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
| Sales, annual | 436.152 | 704.589 | 860.969 | 925.925 | 1142.377 | 1459.996 | 1885.842 | 2109.054 | 2530.234 | 2838.39 |
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
| Sales, quarterly | 533.317 | 536.589 | 558.57 | 603.311 | 659.903 | 708.45 | 706.604 | 707.331 | 716 | |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
| Shares, annual | 35.267 | 35.466 | 35.865 | 35.335 | 35.827 | 31.02 | 30.682 | 30.561 | 28.301 | 27.897 |
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | MRQ |
| Shares, quarterly | 31.012 | 30.561 | 29.766 | 28.019 | 28.098 | 28.301 | 28.49 | 27.841 | 27.897 | |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
Income statement, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,838.39 | 2,530.23 | 2,109.05 | 1,885.84 | 1,460.00 | 1,142.38 | 925.92 | 860.97 | 704.59 |
| Cost of Goods Sold Incl. D&A | 2,038.55 | 1,797.74 | 1,482.00 | 1,387.66 | 1,049.90 | 835.34 | 666.73 | 638.46 | 527.86 |
| Gross Profit | 799.84 | 732.49 | 627.05 | 498.18 | 410.10 | 307.04 | 259.20 | 222.51 | 176.73 |
| Selling, General and Administrative Excl. Other | 192.70 | 197.56 | 180.18 | 161.35 | 131.40 | 108.42 | 92.16 | 95.25 | 75.68 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | 607.14 | 534.93 | 446.87 | 336.82 | 278.70 | 198.62 | 167.04 | 127.26 | 101.05 |
| Interest Expense | - | 0.00 | - | 0.49 | 2.90 | 0.10 | - | 1.57 | 8.16 |
| Unusual Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | 0.00 |
| Net Income Before Taxes | 626.99 | 542.38 | 475.92 | 335.68 | 282.86 | 201.85 | 168.53 | 124.83 | 93.95 |
| Income Taxes | 109.17 | 91.25 | 71.54 | 52.87 | 37.49 | 20.00 | 23.15 | 24.39 | 20.77 |
| Consolidated Net Income | 517.83 | 451.12 | 404.34 | 282.62 | 245.21 | 181.39 | 144.93 | 100.16 | 72.89 |
| Net Income From Continuing Operations | 517.83 | 451.12 | 404.34 | 282.62 | 245.21 | 181.39 | 144.93 | 100.16 | 72.89 |
| Net Income | 517.83 | 451.12 | 404.34 | 282.62 | 245.21 | 181.39 | 144.93 | 100.16 | 72.89 |
| EPS (Recurring) | 18.25 | 15.28 | 12.63 | 8.88 | 7.28 | 4.81 | 3.84 | 2.67 | 1.97 |
| EPS (Basic, Before Extraordinaries) | 18.36 | 15.64 | 13.06 | 9.20 | 7.57 | 5.06 | 4.07 | 2.79 | 2.05 |
| EPS (Diluted) | 18.04 | 15.28 | 12.63 | 8.88 | 7.28 | 4.81 | 3.84 | 2.67 | 1.97 |
| EBITDA | 634.46 | 563.06 | 476.12 | 363.15 | 319.05 | 236.02 | 200.49 | 150.45 | 139.85 |
| Non-Operating Income (Expense) | 19.86 | 7.44 | 29.05 | -0.66 | 7.07 | 3.34 | 1.49 | -0.86 | 1.06 |
| Other After Tax Adjustments | 0.00 | 0.00 | -0.04 | -0.19 | -0.16 | -0.46 | -0.46 | -0.28 | -0.29 |
| Stock Option Compensation Expense | 17.77 | 27.48 | 20.16 | 16.21 | 16.92 | 10.56 | 10.06 | 15.14 | 5.13 |
| Price To Earnings Ratio | 36.84 | 36.84 | 29.09 | 35.92 | 32.58 | 45.21 | 36.22 | 31.58 | 26.74 |
| Price To Sales Ratio | 6.24 | 6.55 | 5.04 | 5.18 | 4.90 | 7.18 | 5.67 | 3.67 | 2.77 |
| Gross Margin | 28.18 | 28.95 | 29.73 | 26.42 | 28.09 | 26.88 | 27.99 | 25.84 | 25.08 |
| Operating Margin | 21.39 | 21.14 | 21.19 | 17.86 | 19.09 | 17.39 | 18.04 | 14.78 | 14.34 |
| Net Margin | 18.24 | 17.83 | 19.17 | 14.99 | 16.80 | 15.88 | 15.65 | 11.63 | 10.35 |
| Shares Outstanding | 27.90 | 28.30 | 30.56 | 30.68 | 31.02 | 35.83 | 35.33 | 35.87 | 35.47 |
| Market Capitalization | 18,588.31 | 18,588.31 | 10,326.24 | 9,405.38 | 6,605.93 | 7,821.81 | 4,979.42 | 3,028.68 | 1,884.57 |
Income statement, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 | 2025Q1 | 2024Q4 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 716.00 | 707.33 | 706.60 | 708.45 | 659.90 | 603.31 | 558.57 | 536.59 |
| Cost of Goods Sold Incl. D&A | 498.69 | 512.40 | 517.18 | 510.26 | 470.01 | 430.31 | 387.15 | 365.78 |
| Gross Profit | 217.31 | 194.93 | 189.42 | 198.19 | 189.89 | 173.00 | 171.42 | 170.81 |
| Selling, General and Administrative Excl. Other | 51.77 | 48.10 | 47.92 | 44.92 | 48.08 | 46.66 | 57.90 | 45.43 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | 165.54 | 146.82 | 141.50 | 153.27 | 141.81 | 126.33 | 113.52 | 125.38 |
| Interest Expense | 0.00 | - | - | 0.00 | - | - | - | - |
| Unusual Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Before Taxes | 170.91 | 151.66 | 147.59 | 156.83 | 142.84 | 124.54 | 118.17 | 133.88 |
| Income Taxes | 33.45 | 30.30 | 23.72 | 21.70 | 31.70 | 34.28 | 3.58 | 16.86 |
| Consolidated Net Income | 137.46 | 121.36 | 123.87 | 135.13 | 111.14 | 90.26 | 114.59 | 117.02 |
| Net Income From Continuing Operations | 137.46 | 121.36 | 123.87 | 135.13 | 111.14 | 90.26 | 114.59 | 117.02 |
| Net Income | 137.46 | 121.36 | 123.87 | 135.13 | 111.14 | 90.26 | 114.59 | 117.02 |
| EPS (Recurring) | 4.84 | 4.25 | 4.28 | 4.67 | 3.86 | 3.10 | 3.67 | 3.67 |
| EPS (Basic, Before Extraordinaries) | 4.92 | 4.31 | 4.35 | 4.78 | 3.95 | 3.16 | 3.77 | 3.78 |
| EPS (Diluted) | 4.84 | 4.25 | 4.28 | 4.67 | 3.86 | 3.10 | 3.67 | 3.67 |
| EBITDA | 172.12 | 153.53 | 148.41 | 160.40 | 148.86 | 133.35 | 120.45 | 132.88 |
| Non-Operating Income (Expense) | 5.37 | 4.84 | 6.09 | 3.56 | 1.03 | -1.80 | 4.65 | 8.50 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 |
| Stock Option Compensation Expense | 6.01 | 3.43 | 3.89 | 4.44 | 5.00 | 4.70 | 13.34 | 4.65 |
| Price To Earnings Ratio | 36.84 | 33.32 | 31.40 | 39.28 | 38.24 | 23.95 | 24.12 | 29.09 |
| Price To Sales Ratio | 6.24 | 5.44 | 5.19 | 6.43 | 6.28 | 4.10 | 4.41 | 5.02 |
| Gross Margin | 30.35 | 27.56 | 26.81 | 27.97 | 28.78 | 28.67 | 30.69 | 31.83 |
| Operating Margin | 23.12 | 20.76 | 20.03 | 21.63 | 21.49 | 20.94 | 20.32 | 23.37 |
| Net Margin | 19.20 | 17.16 | 17.53 | 19.07 | 16.84 | 14.96 | 20.52 | 21.81 |
| Shares Outstanding | 27.90 | 27.84 | 28.49 | 28.30 | 28.10 | 28.02 | 29.77 | 30.56 |
| Market Capitalization | 18,588.31 | 15,124.93 | 13,628.42 | 15,820.67 | 14,444.30 | 9,020.84 | 9,282.93 | 10,326.24 |
Balance sheet, annual
| Metric | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY | 2017FY |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 497.05 | 669.44 | 245.45 | 28.27 | 461.30 | 277.77 | 131.92 | 23.28 | 26.49 |
| Short Term Receivables | 402.08 | 296.44 | 298.40 | 253.40 | 186.43 | 160.96 | 155.66 | 133.45 | 83.08 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 90.50 | 63.35 | 49.98 | 52.29 | 43.18 | 34.92 | 29.45 | 21.38 | 20.40 |
| Total Current Assets | 989.62 | 1,029.23 | 593.83 | 333.96 | 690.91 | 473.65 | 317.03 | 178.11 | 129.97 |
| Net Property, Plant & Equipment | 248.87 | 252.26 | 265.39 | 248.92 | 222.71 | 198.83 | 99.44 | 52.26 | 48.74 |
| Total Investments and Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Intangible Assets | 695.82 | 696.76 | 698.21 | 700.40 | 703.76 | 708.87 | 716.75 | 730.16 | 759.72 |
| Deferred Tax Assets | 19.22 | 100.36 | 74.44 | 48.08 | 25.13 | 0.54 | 0.38 | 0.71 | 6.34 |
| Other Assets | 21.94 | 22.25 | 24.97 | 21.13 | 17.42 | 8.79 | 9.48 | 6.69 | 5.94 |
| Total Assets | 1,975.47 | 2,100.87 | 1,656.83 | 1,352.49 | 1,659.93 | 1,390.68 | 1,143.07 | 967.93 | 950.72 |
| Short Term Debt Incl. Current Port. of LT Debt | 23.21 | 23.29 | 22.36 | 69.27 | 16.28 | 15.89 | 10.98 | 2.10 | 16.50 |
| Accounts Payable | 28.14 | 32.53 | 31.87 | 33.07 | 25.68 | 26.55 | 22.40 | 16.74 | 16.67 |
| Other Current Liabilities | 1,292.40 | 1,048.74 | 870.90 | 701.13 | 515.26 | 397.67 | 309.62 | 238.19 | 159.53 |
| Total Current Liabilities | 1,343.75 | 1,104.55 | 925.13 | 803.47 | 557.22 | 440.11 | 343.00 | 257.03 | 192.71 |
| Long Term Debt | 113.64 | 126.23 | 142.12 | 138.87 | 130.97 | 115.14 | 45.21 | 104.20 | 231.71 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | 9.65 | 8.50 | 7.60 | 4.87 | 3.88 | 15.65 | 14.25 | 8.96 | 0.56 |
| Other Liabilities | 49.35 | 36.03 | 23.02 | 18.90 | 14.95 | 13.99 | 14.32 | 8.04 | 22.21 |
| Total Liabilities | 1,516.40 | 1,275.32 | 1,097.88 | 966.11 | 707.01 | 584.90 | 416.79 | 378.23 | 447.19 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 459.07 | 825.54 | 558.95 | 386.39 | 952.93 | 805.78 | 726.28 | 589.70 | 503.53 |
| Total Shareholders Equity | 459.07 | 825.54 | 558.95 | 386.39 | 952.93 | 805.78 | 726.28 | 589.70 | 503.53 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 459.07 | 825.54 | 558.95 | 386.39 | 952.93 | 805.78 | 726.28 | 589.70 | 503.53 |
| Total Liabilities & Stockholders Equity | 1,975.47 | 2,100.87 | 1,656.83 | 1,352.49 | 1,659.93 | 1,390.68 | 1,143.07 | 967.93 | 950.72 |
| Book Value Per Share | 16.22 | 27.01 | 18.22 | 12.46 | 26.60 | 22.80 | 20.25 | 16.63 | 14.28 |
| Tangible Book Value Per Share | -8.37 | 4.21 | -4.54 | -10.12 | 6.95 | 2.74 | 0.27 | -3.96 | -7.26 |
| Full-Time Employees | 6,200 | 5,900 | 5,900 | 5,200 | 4,500 | 3,600 | 3,500 | 2,900 | 2,500 |
| Price to Book Ratio | 31.69 | 11.69 | 19.97 | 18.88 | 8.18 | 6.10 | 4.15 | 3.18 | 2.46 |
| Return on Assets | 22.13 | 21.52 | 18.78 | 16.28 | 11.89 | 11.44 | 9.49 | 7.60 | 4.05 |
| Return on Equity | 70.23 | 58.41 | 59.79 | 36.62 | 20.63 | 18.92 | 15.22 | 13.34 | 7.01 |
| Return on Invested Capital | 78.77 | 42.48 | 40.31 | 46.68 | 16.74 | 15.74 | 12.98 | 10.50 | 5.31 |
| Quick Ratio | 0.74 | 0.93 | 0.64 | 0.42 | 1.24 | 1.08 | 0.92 | 0.69 | 0.67 |
| Current Ratio | 0.74 | 0.93 | 0.64 | 0.42 | 1.24 | 1.08 | 0.92 | 0.69 | 0.67 |
Cash flow, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | 517.83 | 451.12 | 404.39 | 282.81 | 245.37 | 181.85 | 145.38 | 100.44 | 73.19 |
| Depreciation | 27.33 | 28.12 | 29.25 | 26.33 | 40.36 | 37.41 | 33.45 | 23.19 | 38.80 |
| Other Funds (Non Cash) | 46.47 | 56.92 | 44.63 | 42.87 | 19.29 | 14.48 | 13.06 | 32.60 | 1.05 |
| Funds from Operations | 637.24 | 616.95 | 451.63 | 326.89 | 282.00 | 196.62 | 192.42 | 166.28 | 116.98 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | 85.80 | 96.28 | 157.18 | 106.49 | 106.06 | 66.71 | 66.26 | 35.59 | 39.60 |
| Cash from Operating Activities | 723.05 | 713.22 | 608.82 | 433.37 | 388.05 | 263.33 | 258.68 | 201.87 | 156.58 |
| Capital Expenditures | -55.42 | -31.36 | -36.55 | -36.65 | -36.88 | -28.27 | -31.34 | -17.91 | -16.02 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Purchase or Sale of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | -1.86 | -3.09 | 0.00 | -1.23 | -0.95 |
| Other Sources | 0.18 | 0.22 | 8.24 | 2.02 | 0.00 | 0.00 | 0.13 | 0.00 | 0.00 |
| Cash from Investing Activities | -55.24 | -31.14 | -28.31 | -34.63 | -38.74 | -31.36 | -31.21 | -19.14 | -16.97 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | -246.44 | -860.39 | -154.01 | -132.64 | -825.77 | -44.45 | -82.28 | 6.52 | 2.49 |
| Repurchase of Common Pref Stock | -294.76 | -917.39 | -169.87 | -144.02 | -847.85 | -62.10 | -98.27 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 48.32 | 57.00 | 15.86 | 11.38 | 22.07 | 17.64 | 15.99 | 6.52 | 2.49 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | 0.00 | 0.00 | 0.00 | -50.00 | 50.00 | 0.00 | 0.00 | -80.44 | -144.07 |
| Change in Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -80.44 | -144.07 |
| Issuance of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -80.44 | -144.07 |
| Net Financing Active Other Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Activities Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | -246.44 | -860.39 | -154.01 | -182.64 | -775.77 | -44.45 | -82.28 | -73.92 | -141.58 |
| Exchange Rate Effect | -1.40 | 5.92 | -2.51 | 1.08 | -6.57 | -3.97 | 0.67 | -0.17 | -1.24 |
| Net Change in Cash | 419.96 | -172.39 | 423.99 | 217.18 | -433.04 | 183.54 | 145.85 | 108.64 | -3.21 |
| Free Cash Flow | 667.63 | 681.87 | 572.27 | 396.73 | 351.17 | 235.06 | 227.34 | 183.96 | 140.56 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price to Free Cash Flow | 26.53 | 24.32 | 18.59 | 24.60 | 20.37 | 34.90 | 23.09 | 17.17 | 13.90 |
| Deferred Taxes & Investment Tax Credit | - | 80.77 | -26.63 | -25.12 | -23.01 | -37.11 | 0.53 | 10.05 | 3.94 |
Balance sheet, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 |
|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 705.32 | 502.69 | 652.68 | 497.05 | 285.35 | 46.33 |
| Short Term Receivables | 447.64 | 441.80 | 394.58 | 402.08 | 373.03 | 377.92 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 92.04 | 105.80 | 91.79 | 90.50 | 78.90 | 96.55 |
| Total Current Assets | 1,245.00 | 1,050.29 | 1,139.06 | 989.62 | 737.28 | 520.80 |
| Net Property, Plant & Equipment | 327.55 | 282.96 | 263.36 | 248.87 | 256.76 | 264.99 |
| Total Investments and Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Intangible Assets | 695.35 | 695.51 | 695.66 | 695.82 | 696.05 | 696.29 |
| Deferred Tax Assets | 3.27 | 3.23 | 3.22 | 19.22 | 37.19 | 65.79 |
| Other Assets | 31.42 | 25.20 | 28.32 | 21.94 | 25.72 | 23.80 |
| Total Assets | 2,302.59 | 2,057.18 | 2,129.61 | 1,975.47 | 1,753.01 | 1,571.67 |
| Short Term Debt Incl. Current Port. of LT Debt | 25.42 | 24.01 | 23.84 | 23.21 | 24.91 | 24.89 |
| Accounts Payable | 43.68 | 37.53 | 34.43 | 28.14 | 26.52 | 43.27 |
| Other Current Liabilities | 1,427.00 | 1,373.89 | 1,286.75 | 1,292.40 | 1,232.48 | 1,152.28 |
| Total Current Liabilities | 1,496.10 | 1,435.43 | 1,345.01 | 1,343.75 | 1,283.91 | 1,220.44 |
| Long Term Debt | 146.04 | 120.10 | 122.26 | 113.64 | 119.07 | 124.95 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | 13.66 | 8.21 | 3.92 | 9.65 | 1.90 | 2.02 |
| Other Liabilities | 61.86 | 59.58 | 60.10 | 49.35 | 54.49 | 51.92 |
| Total Liabilities | 1,717.66 | 1,623.32 | 1,531.30 | 1,516.40 | 1,459.37 | 1,399.32 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 584.94 | 433.86 | 598.31 | 459.07 | 293.64 | 172.35 |
| Total Shareholders Equity | 584.94 | 433.86 | 598.31 | 459.07 | 293.64 | 172.35 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 584.94 | 433.86 | 598.31 | 459.07 | 293.64 | 172.35 |
| Total Liabilities & Stockholders Equity | 2,302.59 | 2,057.18 | 2,129.61 | 1,975.47 | 1,753.01 | 1,571.67 |
| Book Value Per Share | 20.97 | 15.58 | 21.00 | 16.22 | 10.45 | 6.15 |
| Tangible Book Value Per Share | -3.96 | -9.40 | -3.42 | -8.37 | -14.32 | -18.70 |
| Full-Time Employees | 6,600 | - | - | 6,200 | - | - |
| Price to Book Ratio | 31.69 | 25.22 | 29.60 | 53.74 | 83.59 | 15.74 |
| Return on Assets | 25.54 | 27.09 | 22.87 | 22.13 | 22.57 | 23.96 |
| Return on Equity | 117.88 | 162.15 | 77.25 | 70.23 | 73.70 | 89.38 |
| Return on Invested Capital | 18.80 | 21.91 | 17.19 | 23.60 | 26.93 | 30.36 |
| Quick Ratio | 0.83 | 0.73 | 0.85 | 0.74 | 0.57 | 0.43 |
| Current Ratio | 0.83 | 0.73 | 0.85 | 0.74 | 0.57 | 0.43 |
Cash flow, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 |
|---|---|---|---|---|---|---|
| Net Income | 137.46 | 121.36 | 123.87 | 135.13 | 111.14 | 90.26 |
| Depreciation | 6.58 | 6.71 | 6.91 | 7.13 | 7.05 | 7.01 |
| Other Funds (Non Cash) | 14.18 | 10.26 | 11.17 | 10.86 | 12.05 | 11.56 |
| Funds from Operations | 163.62 | 142.61 | 160.49 | 170.53 | 158.75 | 142.94 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | 52.98 | 19.40 | -8.70 | 22.12 | 87.46 | 5.59 |
| Cash from Operating Activities | 216.60 | 162.01 | 151.79 | 192.65 | 246.21 | 148.53 |
| Capital Expenditures | -20.16 | -23.91 | -6.81 | -4.54 | -10.71 | -6.11 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.02 | 0.03 | 0.07 | 0.06 | 0.05 | 0.09 |
| Cash from Investing Activities | -20.14 | -23.89 | -6.75 | -4.47 | -10.66 | -6.02 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 6.50 | -288.34 | 12.67 | 22.73 | 3.41 | -540.56 |
| Repurchase of Common Pref Stock | 0.00 | -294.76 | 0.00 | 0.00 | -4.57 | -540.91 |
| Sale of Common Pref Stock | 6.50 | 6.42 | 12.67 | 22.73 | 7.99 | 0.35 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Activities Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | 6.50 | -288.34 | 12.67 | 22.73 | 3.41 | -540.56 |
| Exchange Rate Effect | -0.33 | 0.22 | -2.08 | 0.79 | 0.06 | 2.95 |
| Net Change in Cash | 202.63 | -149.99 | 155.63 | 211.70 | 239.02 | -395.11 |
| Free Cash Flow | 196.44 | 138.10 | 144.97 | 188.12 | 235.50 | 142.41 |
| Price to Free Cash Flow | 26.53 | 21.40 | 19.56 | 23.86 | 21.89 | 15.78 |
Revenue breakdown
| Antiviral And Anti Infective | 2024: 156.46M 2025: 134.94M |
|---|---|
| Cardiology | 2024: 230.45M 2025: 239.37M |
| Central Nervous System | 2024: 181.98M 2025: 254.84M |
| Metabolic | 2024: 457.54M 2025: 744.96M |
| Oncology | 2024: 651.24M 2025: 747.59M |
| Other | 2024: 431.38M 2025: 408.55M |
| United States | 2024: 2.11B 2025: 2.53B |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 6.09% | 1.4M | 22.7M | 258.36K |
| 2026-10-15 | 7.10% | 1.6M | 22.7M | 271.09K |
| 2026-09-30 | 7.06% | 1.6M | 22.6M | 280.11K |
| 2026-09-15 | 7.49% | 1.7M | 22.5M | 294.14K |
| 2026-08-31 | 7.44% | 1.7M | 22.5M | 302.58K |
| 2026-08-14 | 7.04% | 1.6M | 22.4M | 320.54K |
| 2026-07-31 | 7.76% | 1.7M | 22.5M | 344.25K |
| 2026-07-15 | 9.52% | 2.2M | 23.0M | 371.20K |
| 2026-06-30 | 9.24% | 2.1M | 23.0M | 374.85K |
| 2026-06-15 | 9.08% | 2.1M | 23.0M | 362.72K |
| 2026-05-29 | 8.93% | 2.1M | 23.0M | 376.32K |
| 2026-05-15 | 8.28% | 1.9M | 23.0M | 389.77K |
| 2026-04-30 | 6.75% | 1.6M | 23.0M | 430.78K |
| 2026-04-15 | 5.87% | 1.3M | 23.0M | 359.36K |
| 2026-03-31 | 5.32% | 1.2M | 22.9M | 340.05K |
| 2026-03-13 | 6.14% | 1.4M | 22.8M | 322.49K |
| 2026-02-27 | 5.63% | 1.3M | 22.8M | 313.46K |
| 2026-02-13 | 5.65% | 1.3M | 22.8M | 293.07K |
| 2026-01-30 | 5.92% | 1.3M | 22.7M | 236.65K |
| 2026-01-15 | 6.05% | 1.4M | 22.7M | 269.70K |
Option chain
expiry 2026-11-20| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| call | 410 | 251.7 | 260 | 0.00 | 1.998 | 0.00 | 0.00 | 0.973 | -0.667 | 0.064 |
| call | 420 | 241.7 | 250 | 0.00 | 1.914 | 0.00 | 0.00 | 0.972 | -0.663 | 0.066 |
| call | 430 | 233 | 239 | 0.00 | 1.841 | 0.00 | 0.00 | 0.971 | -0.658 | 0.068 |
| call | 440 | 223 | 229 | 0.00 | 1.823 | 0.00 | 0.00 | 0.970 | -0.653 | 0.071 |
| call | 450 | 212.9 | 218.9 | 176.24 | 1.706 | 1.00 | 0.00 | 0.968 | -0.648 | 0.074 |
| call | 460 | 203 | 208.5 | 0.00 | 1.660 | 0.00 | 0.00 | 0.967 | -0.642 | 0.076 |
| call | 470 | 191.3 | 199.1 | 0.00 | 1.581 | 0.00 | 0.00 | 0.965 | -0.637 | 0.080 |
| call | 480 | 181.3 | 189.1 | 140.34 | 1.448 | 7.00 | 0.00 | 0.963 | -0.630 | 0.083 |
| call | 490 | 173 | 178.6 | 190 | 1.374 | 1.00 | 0.00 | 0.962 | -0.624 | 0.086 |
| call | 500 | 161.3 | 169 | 136.9 | 1.359 | 1.00 | 0.00 | 0.960 | -0.617 | 0.090 |
| call | 510 | 152.5 | 159.1 | 0.00 | 1.284 | 0.00 | 0.00 | 0.957 | -0.609 | 0.094 |
| call | 520 | 141.6 | 149.1 | 0.00 | 1.163 | 0.00 | 0.00 | 0.955 | -0.601 | 0.098 |
| call | 530 | 131.4 | 139.1 | 0.00 | 1.144 | 0.00 | 0.00 | 0.952 | -0.592 | 0.103 |
| call | 540 | 121.8 | 129.2 | 0.00 | 1.071 | 0.00 | 0.00 | 0.949 | -0.583 | 0.109 |
| call | 550 | 111.3 | 119.3 | 132.65 | 1.005 | 2.00 | 0.00 | 0.945 | -0.572 | 0.114 |
| call | 560 | 101.6 | 109.4 | 122.95 | 0.939 | 3.00 | 0.00 | 0.936 | -0.615 | 0.130 |
| call | 570 | 92.10 | 99.60 | 0.00 | 0.887 | 0.00 | 0.00 | 0.891 | -0.987 | 0.193 |
| call | 580 | 83.50 | 89.80 | 96.80 | 0.810 | 3.00 | 0.00 | 0.883 | -0.957 | 0.203 |
| call | 590 | 73.60 | 79.90 | 71.92 | 0.720 | 1.00 | 0.00 | 0.873 | -0.924 | 0.215 |
| call | 600 | 64.10 | 69.90 | 71.08 | 0.665 | 15.00 | 0.00 | 0.861 | -0.888 | 0.229 |
| call | 610 | 55.00 | 60.60 | 0.00 | 0.616 | 0.00 | 0.00 | 0.845 | -0.856 | 0.246 |
| call | 620 | 46.10 | 50.80 | 69.60 | 0.565 | 5.00 | 0.00 | 0.824 | -0.826 | 0.267 |
| call | 630 | 37.30 | 43.10 | 25.00 | 0.518 | 3.00 | 0.00 | 0.755 | -1.052 | 0.325 |
| call | 640 | 29.30 | 35.20 | 25.90 | 0.494 | 5.00 | 0.00 | 0.707 | -1.043 | 0.356 |
| call | 650 | 22.00 | 28.40 | 28.78 | 0.500 | 19.00 | 0.00 | 0.635 | -1.123 | 0.389 |
| call | 660 | 16.30 | 23.00 | 20.50 | 0.491 | 17.00 | 0.00 | 0.558 | -1.153 | 0.408 |
| call | 670 | 10.90 | 18.00 | 14.00 | 0.488 | 21.00 | 1.00 | 0.477 | -1.130 | 0.412 |
| call | 680 | 8.00 | 14.00 | 16.96 | 0.491 | 25.00 | 0.00 | 0.399 | -1.100 | 0.399 |
| call | 690 | 2.30 | 10.70 | 21.00 | 0.501 | 28.00 | 0.00 | 0.330 | -1.057 | 0.374 |
| call | 700 | 1.30 | 9.90 | 5.09 | 0.548 | 370 | 0.00 | 0.281 | -1.053 | 0.349 |
| call | 710 | 0.05 | 8.00 | 6.78 | 0.562 | 48.00 | 0.00 | 0.232 | -0.977 | 0.315 |
| call | 720 | 0.05 | 7.50 | 3.78 | 0.611 | 27.00 | 0.00 | 0.213 | -1.037 | 0.300 |
| call | 730 | 0.05 | 7.20 | 3.19 | 0.662 | 0.00 | 0.00 | 0.197 | -1.086 | 0.287 |
| call | 740 | 0.00 | 4.90 | 1.30 | 0.632 | 22.00 | 0.00 | 0.151 | -0.876 | 0.242 |
| call | 750 | 0.00 | 4.90 | 1.30 | 0.684 | 29.00 | 0.00 | 0.142 | -0.909 | 0.232 |
| call | 760 | 0.00 | 4.90 | 1.05 | 0.734 | 17.00 | 0.00 | 0.134 | -0.939 | 0.224 |
| call | 770 | 0.00 | 4.90 | 2.72 | 0.783 | 4.00 | 0.00 | 0.128 | -0.967 | 0.216 |
| call | 780 | 0.00 | 4.90 | 3.10 | 0.830 | 6.00 | 0.00 | 0.122 | -0.992 | 0.209 |
| call | 790 | 0.00 | 4.90 | 0.81 | 0.876 | 17.00 | 0.00 | 0.117 | -1.016 | 0.203 |
| call | 800 | 0.00 | 4.90 | 10.00 | 0.921 | 17.00 | 0.00 | 0.112 | -1.038 | 0.198 |
| call | 810 | 0.00 | 4.90 | 0.90 | 0.965 | 15.00 | 0.00 | 0.108 | -1.059 | 0.193 |
| call | 820 | 0.00 | 4.90 | 3.40 | 1.008 | 16.00 | 0.00 | 0.105 | -1.079 | 0.188 |
| call | 830 | 0.00 | 4.90 | 0.00 | 1.049 | 0.00 | 0.00 | 0.102 | -1.097 | 0.184 |
| call | 840 | 0.00 | 4.90 | 0.00 | 1.090 | 0.00 | 0.00 | 0.099 | -1.115 | 0.180 |
| call | 850 | 0.00 | 4.90 | 0.00 | 1.129 | 0.00 | 0.00 | 0.096 | -1.132 | 0.176 |
| call | 860 | 0.00 | 4.90 | 3.30 | 1.168 | 0.00 | 0.00 | 0.093 | -1.148 | 0.173 |
| call | 870 | 0.00 | 4.90 | 0.05 | 1.207 | 16.00 | 0.00 | 0.091 | -1.163 | 0.169 |
| call | 880 | 0.00 | 4.90 | 0.00 | 1.244 | 0.00 | 0.00 | 0.089 | -1.178 | 0.166 |
| call | 890 | 0.00 | 4.90 | 0.00 | 1.281 | 0.00 | 0.00 | 0.087 | -1.192 | 0.164 |
| put | 410 | 0.00 | 4.90 | 0.85 | 1.719 | 2.00 | 0.00 | -0.026 | -0.597 | 0.062 |
| put | 420 | 0.00 | 4.90 | 1.80 | 1.656 | 2.00 | 0.00 | -0.028 | -0.616 | 0.066 |
| put | 430 | 0.00 | 4.90 | 2.19 | 1.583 | 2.00 | 0.00 | -0.029 | -0.610 | 0.068 |
| put | 440 | 0.00 | 4.90 | 1.05 | 1.512 | 2.00 | 0.00 | -0.030 | -0.604 | 0.071 |
| put | 450 | 0.00 | 4.90 | 1.34 | 1.441 | 10.00 | 0.00 | -0.032 | -0.598 | 0.074 |
| put | 460 | 0.00 | 4.90 | 2.10 | 1.372 | 2.00 | 0.00 | -0.033 | -0.591 | 0.076 |
| put | 470 | 0.00 | 4.90 | 0.38 | 1.304 | 13.00 | 0.00 | -0.035 | -0.584 | 0.080 |
| put | 480 | 0.00 | 4.90 | 0.05 | 1.238 | 11.00 | 0.00 | -0.037 | -0.577 | 0.083 |
| put | 490 | 0.00 | 4.90 | 0.01 | 1.172 | 4.00 | 0.00 | -0.038 | -0.569 | 0.086 |
| put | 500 | 0.00 | 4.90 | 0.40 | 1.107 | 7.00 | 0.00 | -0.040 | -0.561 | 0.090 |
| put | 510 | 0.00 | 4.90 | 5.46 | 1.044 | 2.00 | 0.00 | -0.043 | -0.552 | 0.094 |
| put | 520 | 0.00 | 4.90 | 1.36 | 0.981 | 3.00 | 0.00 | -0.045 | -0.543 | 0.098 |
| put | 530 | 0.00 | 4.90 | 0.83 | 0.918 | 5.00 | 0.00 | -0.048 | -0.533 | 0.103 |
| put | 540 | 0.00 | 4.90 | 2.23 | 0.857 | 10.00 | 0.00 | -0.051 | -0.522 | 0.109 |
| put | 550 | 0.00 | 2.00 | 0.69 | 0.778 | 3.00 | 0.00 | -0.060 | -0.510 | 0.130 |
| put | 560 | 0.00 | 4.90 | 1.71 | 0.759 | 91.00 | 0.00 | -0.064 | -0.553 | 0.130 |
| put | 570 | 0.00 | 4.90 | 0.93 | 0.853 | 42.00 | 0.00 | -0.109 | -0.923 | 0.193 |
| put | 580 | 0.00 | 4.90 | 1.81 | 0.686 | 11.00 | 0.00 | -0.090 | -0.646 | 0.168 |
| put | 590 | 0.00 | 4.90 | 5.05 | 0.713 | 205 | 0.00 | -0.127 | -0.859 | 0.215 |
| put | 600 | 0.05 | 4.90 | 2.74 | 0.642 | 55.00 | 0.00 | -0.139 | -0.821 | 0.229 |
| put | 610 | 0.05 | 5.80 | 2.08 | 0.571 | 7.00 | 4.00 | -0.155 | -0.788 | 0.246 |
| put | 620 | 0.05 | 4.90 | 2.76 | 0.499 | 44.00 | 2.00 | -0.176 | -0.757 | 0.267 |
| put | 630 | 1.70 | 8.80 | 7.55 | 0.552 | 55.00 | 0.00 | -0.245 | -0.982 | 0.325 |
| put | 640 | 2.90 | 9.80 | 16.80 | 0.494 | 20.00 | 0.00 | -0.293 | -0.971 | 0.356 |
| put | 650 | 5.60 | 13.00 | 8.60 | 0.485 | 58.00 | 2.00 | -0.365 | -1.050 | 0.389 |
| put | 660 | 10.80 | 16.90 | 20.00 | 0.474 | 5.00 | 0.00 | -0.442 | -1.079 | 0.408 |
| put | 670 | 15.00 | 21.00 | 25.10 | 0.450 | 10.00 | 0.00 | -0.523 | -1.056 | 0.412 |
| put | 680 | 20.70 | 26.90 | 20.00 | 0.449 | 6.00 | 0.00 | -0.601 | -1.024 | 0.399 |
| put | 690 | 27.40 | 34.00 | 26.40 | 0.459 | 17.00 | 0.00 | -0.670 | -0.980 | 0.374 |
| put | 700 | 34.30 | 41.00 | 86.30 | 0.447 | 16.00 | 0.00 | -0.719 | -0.976 | 0.349 |
| put | 710 | 44.30 | 50.20 | 0.00 | 0.415 | 0.00 | 0.00 | -0.768 | -0.898 | 0.315 |
| put | 720 | 52.30 | 58.80 | 0.00 | 0.497 | 0.00 | 0.00 | -0.787 | -0.957 | 0.300 |
| put | 730 | 62.00 | 68.00 | 0.00 | 0.518 | 0.00 | 0.00 | -0.803 | -1.005 | 0.287 |
| put | 740 | 71.70 | 77.90 | 0.00 | 0.565 | 0.00 | 0.00 | -0.849 | -0.794 | 0.242 |
| put | 750 | 81.00 | 88.90 | 0.00 | 0.610 | 0.00 | 0.00 | -0.858 | -0.826 | 0.232 |
| put | 760 | 91.60 | 99.20 | 0.00 | 0.658 | 0.00 | 0.00 | -0.866 | -0.855 | 0.224 |
| put | 770 | 101.5 | 109 | 0.00 | 0.704 | 0.00 | 0.00 | -0.872 | -0.881 | 0.216 |
| put | 780 | 111.6 | 119.6 | 0.00 | 0.749 | 0.00 | 0.00 | -0.878 | -0.906 | 0.209 |
| put | 790 | 121.6 | 129.2 | 0.00 | 0.794 | 0.00 | 0.00 | -0.883 | -0.928 | 0.203 |
| put | 800 | 131.6 | 139.1 | 0.00 | 0.836 | 0.00 | 0.00 | -0.888 | -0.949 | 0.198 |
| put | 810 | 142 | 150 | 0.00 | 0.878 | 0.00 | 0.00 | -0.892 | -0.969 | 0.193 |
| put | 820 | 152 | 158.2 | 0.00 | 0.919 | 0.00 | 0.00 | -0.895 | -0.987 | 0.188 |
| put | 830 | 161.5 | 169.2 | 0.00 | 0.959 | 0.00 | 0.00 | -0.898 | -1.005 | 0.184 |
| put | 840 | 171.5 | 179.2 | 211.3 | 0.999 | 0.00 | 0.00 | -0.901 | -1.021 | 0.180 |
| put | 850 | 181.5 | 189.2 | 0.00 | 1.037 | 0.00 | 0.00 | -0.904 | -1.037 | 0.176 |
| put | 860 | 191.5 | 199.2 | 0.00 | 1.075 | 0.00 | 0.00 | -0.907 | -1.052 | 0.173 |
| put | 870 | 201.5 | 209.2 | 240.3 | 1.112 | 0.00 | 0.00 | -0.909 | -1.066 | 0.169 |
| put | 880 | 211.5 | 219.3 | 0.00 | 1.148 | 0.00 | 0.00 | -0.911 | -1.080 | 0.166 |
| put | 890 | 221.6 | 229.2 | 0.00 | 1.184 | 0.00 | 0.00 | -0.913 | -1.093 | 0.164 |
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-11-02 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-29 | SEC |
| 2026-10-29 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-10-28 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-26 | SEC |
| 2026-10-27 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-10-26 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-10-23 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-21 | SEC |
| 2026-10-22 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-09-30 | SEC |
| 2026-10-21 | 8-K | Current report | 2026-10-20 | SEC |
| 2026-10-14 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-12 | SEC |
| 2026-10-09 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-07 | SEC |
| 2026-10-02 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-30 | SEC |
| 2026-10-02 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-30 | SEC |
| 2026-10-02 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-30 | SEC |
| 2026-10-01 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-29 | SEC |
| 2026-09-29 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-25 | SEC |
| 2026-09-28 | SCHEDULE 13D/A | SEC | ||
| 2026-09-25 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-23 | SEC |
| 2026-09-23 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-21 | SEC |
| 2026-09-21 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-17 | SEC |
| 2026-09-17 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-15 | SEC |
| 2026-09-17 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-15 | SEC |
| 2026-08-31 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-27 | SEC |
| 2026-08-28 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-26 | SEC |
| 2026-08-27 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-25 | SEC |
| 2026-08-26 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-08-25 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-21 | SEC |
| 2026-08-24 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-20 | SEC |
| 2026-08-21 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-19 | SEC |
| 2026-08-21 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-19 | SEC |
| 2026-08-21 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-19 | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 0 | 0 |
| 2026-10 | 0 | 0 | 14.40M | 3 |
| 2026-09 | 0 | 0 | 125.86M | 11 |
| 2026-08 | 0 | 0 | 73.77M | 17 |
| 2026-07 | 0 | 0 | 8.85M | 3 |
| 2026-06 | 0 | 0 | 0 | 0 |
| 2026-05 | 0 | 0 | 7.36M | 1 |
| 2026-04 | 0 | 0 | 0 | 0 |
| 2026-03 | 0 | 0 | 14.44M | 1 |
| 2026-02 | 0 | 0 | 0 | 0 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 0 | 0 | 17.51M | 3 |
| 2025-11 | 0 | 0 | 191.57M | 17 |
Institutional holders
| Manager | % owned |
|---|---|
| BlackRock, Inc. | 8.75% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 7.25% |
| AQR CAPITAL MANAGEMENT LLC | 4.48% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.97% |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.60% |
| GEODE CAPITAL MANAGEMENT, LLC | 2.55% |
| STATE STREET CORP | 2.49% |
| Invesco Ltd. | 2.03% |
| WASATCH ADVISORS LP | 1.67% |
| BAILLIE GIFFORD & CO | 1.62% |
Funds
| Fund | % owned |
|---|---|
| iShares Core S&P Mid-Cap ETF | 2.70% |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | 2.54% |
| VANGUARD SMALL-CAP INDEX FUND | 1.83% |
| T. Rowe Price Large-Cap Growth Fund | 1.32% |
| Invesco S&P MidCap Quality ETF | 1.06% |
| VANGUARD SMALL-CAP GROWTH INDEX FUND | 1.06% |
| VANGUARD EXPLORER FUND | 0.97% |
| VANGUARD EXTENDED MARKET INDEX FUND | 0.91% |
| State Street SPDR S&P MidCap 400SM ETF Trust | 0.61% |
| FULLERTHALER BEHAVIORAL SMALL CAP EQUITY | 0.61% |
OakChart. MEDP. Cached 15 minutes.